<i>In Silico</i> Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes

<table>Scaffold of top 2 candidate compounds: (a) eugenyl_beta-D-glucopyranoside, (b) 6-O-cinnamoyl-D-glucopyranose, and the control (c) AMP.</table>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: <i>In Silico</i> Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes 

Figure 4 | In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes 